tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
3M ago
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
3M ago
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
Premium
Company Announcements
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
3M ago
Neuroscientific Biopharmaceuticals Issues New Equity Securities
PremiumCompany AnnouncementsNeuroscientific Biopharmaceuticals Issues New Equity Securities
4M ago
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Ltd. Releases Corporate Governance Statement
5M ago
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Faces Financial Challenges Amidst Industry Struggles
5M ago
NeuroScientific Biopharmaceuticals Appoints Dr. Catherine Cole as Chief Medical Officer
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Appoints Dr. Catherine Cole as Chief Medical Officer
6M ago
NeuroScientific Biopharmaceuticals Expands Stem Cell Therapy Portfolio with Key Acquisition
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Expands Stem Cell Therapy Portfolio with Key Acquisition
6M ago
NeuroScientific Biopharmaceuticals Director Increases Shareholding
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Director Increases Shareholding
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100